"Victoza" - Google News

16 January 2019

• Novo Nordisk Boasts Strong Diabetes Presence and Pipeline - Nasdaq
• 5 Reasons Why Investors Should Buy Novo Nordisk (NVO) in 2019 - Zacks.com
• Two common diabetes drugs linked to heart attack, stroke risk - UPI News
• Todd Hobbs Part 1, The Pioneer One Study - Oral Semaglutide - Diabetes In Control
• Oral semaglutide demonstrates greater reductions in both HbA1c and body weight compared to Victoza® in Japanese people with type 2 diabetes - GlobeNewswire